The stock prices of major cannabis companies like Tilray Brands (NASDAQ:TLRY) and Canopy Growth (NASDAQ:CGC) skyrocketed 34.88% and 27.46%, respectively, in premarket trading on Friday, following reports of President Donald Trump‘s plans to relax federal regulations on marijuana. Meanwhile, Aurora Cannabis Inc. (NASDAQ:ACB) surged 20%, Cronos Group Inc. (NASDAQ:CRON) gained 19% and Organigram Global Inc. (NASDAQ:OGI), and SNDL Inc. (NASDAQ:SNDL) rose 12% and 34.7% respectively. Reclassification Of Cannabis ...

Market Analysis by covering: Tilray Inc. Read 's Market Analysis on Investing.com ...

智通财经APP获悉，多家美国当地媒体报道称，美国总统唐纳德·特朗普预计将推动把大麻重新归类 为"危害性较低的药物"，这一最新的市场动态无疑直接推动美国大麻类生产商股票周五在美股盘前交易 中大幅上涨。涨幅居前的包括：Tilray Brands(TLRY.US)盘前大涨超30%，Canopy Growth(CGC.US)涨 23%，Aurora Cannabis(ACB.US)涨20%，SNDL(SNDL.US)涨14%，Cronos Group(CRON.US)涨12%。 根据媒体报道，特朗普正在考虑将大麻从"附表I"(Schedule I)——该类别表示无医疗用途且具有高滥用 潜力——大幅度调整至"附表III"——这是一类依赖性与成瘾性潜力较低的物质类别。 据报道，特朗普当地时间周四早些时候与美国众议院议长迈克·约翰逊、特朗普亲自提名的卫生与公众 服务部(HHS)部长小罗伯特·F·肯尼迪、医疗保险和医疗补助服务中心(CMS)署长梅赫梅特·奥兹，以及数 位大麻行业高管通话，讨论该事项。 不过报道称，联系到的一名白宫高级官员表示，特朗普本人尚未给出最终的行政决定。 附表III药物具有已被普遍接受的医疗用途，但仍存 ...

Tilray Brands stock price has rebounded in the past three days, and chances are that the surge will accelerate as a new catalyst emerges. TLRY rose to $8.43, a few days after the company completed its... ...

核心事件与市场反应 - 美国总统特朗普预计将指示相关机构将大麻重新分类为第三类管制药物 此举将显著放宽联邦层面的限制 [2] - 受此消息影响 大麻类股票在周五盘前交易中大幅上涨 其中生产商Tilray Brands暴涨超过28% Canopy Growth飙升23% 大麻设施运营商Innovative Industrial Properties涨幅超过6% [1] - 重新分类预计将在明年初实施 将大麻从与海洛因同等的类别移至危险性较低的类别 [2] 政策变化的具体影响 - 重新分类为第三类药物将使大麻公司适用不同的税收规定 从而鼓励对该行业的投资 [2] - 第三类药物类别包括类固醇和含可待因的泰诺等药物 [2] 行业背景与公司状况 - 大麻股自大约七年前许多公司上市以来一直表现挣扎 尽管社会接受度提高且各州层面分类放宽 [3] - 在周五上涨前 Tilray股价今年已下跌36% [3] - 特朗普曾在今年8月提出改变大麻分类的想法 [3]

U.S. stock futures swung between gains and losses on Friday after Thursday’s mixed close. Futures of major benchmark indices were mixed.Thursday experienced a rotation out of expensive tech names, which helped U.S. stocks settle mostly higher, with the Dow Jones surging over 600 points. Overall risk appetite remained resilient following the Federal Reserve's third consecutive interest-rate cut delivered a day earlier. Meanwhile, President Donald Trump signed a sweeping executive order aimed at creating a si ...

cbdMD Inc. (NYSEAMERICAN: YCBD) shares rose 54.64% in after-hours trading on Thursday, climbing to $0.98 after the company announced it had regained full compliance with NYSE American listing standards.Check out the current price of YCBD stock here.According to Benzinga Pro data, the stock closed on Thursday at $0.63, down 0.63%.Exchange Compliance RestoredThe Charlotte-based wellness and hemp-derived products company said Monday that the NYSE American removed its ".BC" noncompliant issuer label at the star ...

TORONTO, Dec. 11, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle and consumer packaged goods company at the forefront of the cannabis, beverage and wellness industries, announces the launch of Amped Live Resin Liquid Diamond 1g 510 cartridges, marking Redecan’s first live resin–liquid diamond line for the brand. The debut lineup, Space Age CK and Blueberry DNTS, pairs Redecan’s Legit Live Resin with Liquid Diamonds to deliver a true‑to‑strain flavour an ...

Tilray Brands Inc (NASDAQ:TLRY) experiences a significant stock price recovery, surging over 12% after a challenging period.The company underwent a 1-for-10 reverse stock split, reducing its float and potentially contributing to recent stock price movements.Tilray's market capitalization stands at approximately $924.94 million, with a year of high volatility, indicating the dynamic nature of the cannabis industry.Tilray Brands Inc (NASDAQ:TLRY) is a prominent player in the cannabis industry, known for its p ...

We recently published Small But Savage: 10 Stocks Delivering Outsized Gains. Tilray Brands, Inc. (NASDAQ:TLRY) is one of the best performers on Tuesday. Tilray Brands bounced back by 12.36 percent on Tuesday to close at $8.09 apiece as investor optimism was bolstered by the submission of a new Senate bill, which aims to legalize home cultivation of marijuana in Florida. On Friday, Sen. Carlos Smith filed the legislation seeking to permit qualified patients aged 21 and above to cultivate up to six floweri ...